PCK2 and cancer: This scenario indicates that glucose and PEPCK-M are supporting, through the PEP/Ca2+ axis, a proliferative state in tumors, and bring about the importance of this target for cancer metabolism, as exemplified by the efficacy of potent inhibitors of this pathway in pre-clinical studies [22].